Pharma & Biopharma

An MS-based algorithm could transform natural product drug discovery

Gas generation presents a safer, more cost-effective, and more reliable alternative to traditional tanks – is it time you made the switch?

What makes native LC-MS so powerful when it comes to biopharmaceutical analysis?

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.

Anna Cousens, Global Analytical BDM at Almac Sciences, discusses ICP-MS analysis and the importance of getting it right in drug development

Are your capsids full, half full, or empty? We need better analytical techniques to find out.

Our best pharma content from 2020 in one convenient place

KNAUER’s Matthias Luebbert discusses the company’s recent move into lipid nanoparticles

Michael Kurczy and Alison Hulme discuss their forays into the field of subcellular drug imaging

Davy discusses his work in HPLC for pharmaceutical applications and influential mentors